Extracellular matrix protein 1 interacts with the domain III of fibulin-1C and 1D variants through its central tandem repeat 2

被引:37
作者
Fujimoto, N
Terlizzi, J
Brittingham, R
Fertala, A
McGrath, JA
Uitto, J [1 ]
机构
[1] Thomas Jefferson Univ, Jefferson Med Coll, Philadelphia, PA 19107 USA
[2] Thomas Jefferson Univ, Jefferson Inst Mol Med, Philadelphia, PA 19107 USA
[3] GKT, Sch Med, St Johns Inst Dermatol, Genet Skin Dis Grp, London, England
关键词
extracellular matrix of connective tissue; extracellular matrix protein 1; fibulin-1 splice variants; protein-protein; interactions;
D O I
10.1016/j.bbrc.2005.06.046
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Extracellular matrix protein 1 (ECM1), a widely expressed glycoprotein, has been shown to harbor mutations in lipoid proteinosis (LP), an autosomal recessive disorder characterized by profound alterations in the extracellular matrix of connective tissue. The biological function of ECM1 and its role in the pathomechanisms of LP are unknown. Fibulins comprise a family of extracellular matrix components, and the prototype of this family, fibulin-1, is expressed in various connective tissues and plays a role in developmental and pathologic processes. In this study, we demonstrate that ECM1, and specifically the second tandem repeat domain which is alternatively spliced, interacts with the C-terminal segments of fibulins I C and I D splice variants which differ in their C-terminal domain III. The interactions were detected by yeast two-hybrid genetic system and confirmed by co-immunoprecipitations. Kinetics of the binding between ECM1 and fibulin-ID, measured by biosensor assay, revealed a K-d of 5.71 x 10(-8) M, indicating a strong protein-protein interaction. Since distinct splice variants of ECM1 and fibulin-1 have been shown to be co-expressed in tissues affected in LP, we propose that altered ECM1/fibulin-1 interactions may play a role in the pathogenesis of this disease as well as in a number of processes involving the extracellular matrix of connective tissues. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:1327 / 1333
页数:7
相关论文
共 22 条
  • [1] Fibulins: physiological and disease perspectives
    Argraves, WS
    Greene, LM
    Cooley, MA
    Gallagher, WM
    [J]. EMBO REPORTS, 2003, 4 (12) : 1127 - 1131
  • [2] FIBULIN, A NOVEL PROTEIN THAT INTERACTS WITH THE FIBRONECTIN RECEPTOR-BETA SUBUNIT CYTOPLASMIC DOMAIN
    ARGRAVES, WS
    DICKERSON, K
    BURGESS, WH
    RUOSLAHTI, E
    [J]. CELL, 1989, 58 (04) : 623 - 629
  • [3] MOLECULAR-CLONING, CHARACTERIZATION, AND GENETIC-MAPPING OF THE CDNA CODING FOR A NOVEL SECRETORY PROTEIN OF MOUSE - DEMONSTRATION OF ALTERNATIVE SPLICING IN SKIN AND CARTILAGE
    BHALERAO, J
    TYLZANOWSKI, P
    FILIE, JD
    KOZAK, CA
    MERREGAERT, J
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (27) : 16385 - 16394
  • [4] The fibulin-1 gene (FBLN1) is disrupted in a t(12;22) associated with a complex type of synpolydactyly
    Debeer, P
    Schoenmakers, EFPM
    Twal, WO
    Argraves, WS
    De Smet, L
    Fryns, JP
    Van de Ven, WJM
    [J]. JOURNAL OF MEDICAL GENETICS, 2002, 39 (02) : 98 - 104
  • [5] Recombinant human extracellular matrix protein 1 inhibits alkaline phosphatase activity and mineralization of mouse embryonic metatarsals in vitro
    Deckers, MML
    Smits, P
    Karperien, M
    Ni, J
    Tylzanowski, P
    Feng, P
    Parmelee, D
    Zhang, J
    Bouffard, E
    Gentz, R
    Löwik, CWG
    Merregaert, J
    [J]. BONE, 2001, 28 (01) : 14 - 20
  • [6] Identification of breast cancer-restricted antigens by antibody screening of SKBR3 cDNA library using a preselected patient's serum
    Forti, S
    Scanlan, MJ
    Invernizzi, A
    Castiglioni, F
    Pupa, S
    Agresti, R
    Fontanelli, R
    Morelli, D
    Old, LJ
    Pupa, SM
    Ménard, S
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2002, 73 (03) : 245 - 256
  • [7] Elevated expression and altered processing of fibulin-1 protein in human breast cancer
    Greene, LM
    Twal, WO
    Duffy, MJ
    McDermott, EW
    Hill, AD
    O'Higgins, NJ
    McCann, A
    Dervan, P
    Argraves, W
    Gallagher, WM
    [J]. BRITISH JOURNAL OF CANCER, 2003, 88 (06) : 871 - 878
  • [8] Extracellular matrix protein 1 gene (ECM1) mutations in lipoid proteinosis and genotype-phenotype correlation
    Hamada, T
    Wessagowit, V
    South, AP
    Ashton, GHS
    Chan, I
    Oyama, N
    Siriwattana, A
    Jewhasuchin, P
    Charuwichitratana, S
    Thappa, DM
    Lenane, P
    Krafchik, B
    Kulthanan, K
    Shimizu, H
    Kaya, TI
    Erdal, ME
    Paradisi, M
    Paller, AS
    Seishima, M
    Hashimoto, T
    McGrath, AA
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2003, 120 (03) : 345 - 350
  • [9] Lipoid proteinosis maps to 1q21 and is caused by mutations in the extracellular matrix protein 1 gene (ECM1)
    Hamada, T
    McLean, WHI
    Ramsay, M
    Ashton, GHS
    Nanda, A
    Jenkins, T
    Edelstein, I
    South, AP
    Bleck, O
    Wessagowit, V
    Mallipeddi, R
    Orchard, GE
    Wan, H
    Dopping-Hepenstal, PJC
    Mellerio, JE
    Whittock, NV
    Munro, CS
    van Steensel, MAM
    Steijlen, PM
    Ni, J
    Zhang, LR
    Hashimoto, T
    Eady, RAJ
    McGrath, JA
    [J]. HUMAN MOLECULAR GENETICS, 2002, 11 (07) : 833 - 840
  • [10] Extracellular matrix protein 1 (ECM1) has angiogenic properties and is expressed by breast tumor cells
    Han, ZQ
    Ni, J
    Smits, P
    Underhill, CB
    Xie, B
    Chen, YX
    Liu, NF
    Tylzanowski, P
    Parmelee, D
    Feng, P
    Ding, I
    Gao, F
    Gentz, R
    Huylebroeck, D
    Merregaert, J
    Zhang, LR
    [J]. FASEB JOURNAL, 2001, 15 (06) : 988 - 994